PIP-II progress: working toward CD-1

Steve Holmes

Steve Holmes

Reviews are sometimes viewed as one of the more onerous costs of doing business at Fermilab. But they are also a measure of progress, especially with projects that are coming to life within the DOE system.

So it is with PIP-II. The first Independent Project Review of the PIP-II project since achieving formal project status within DOE was conducted from Nov. 15-16 at Fermilab. The DOE review committee came to assess progress within the PIP-II R&D program and through the more formalized project activities aimed at the next step: Critical Decision-1 (CD-1).

Both Fermilab staff and our collaborators from the Indian Department of Atomic Energy laboratories presented at the review. These talks centered around the Conceptual Design Report — describing the 800-MeV superconducting linac that is the centerpiece of PIP-II, along with improvements to the existing accelerators required to provide 1.2 megawatts of beam power at the time of startup of the LBNF/DUNE program in the middle of the next decade.

We highlighted progress on a broad front, encompassing the PIP-II Injector Test (PIP2IT) facility, the superconducting RF program, and studies and simulations in the existing accelerators. We also covered the Resource Loaded Schedule, Preliminary Project Execution Plan, Cost Estimate and the Joint R&D Plan with India.

The review committee concluded that the project is ahead of pace on the technical development but somewhat behind pace on the project development aspects of getting to CD-1. The PIP-II project felt this was a fair conclusion, and we are developing a plan to complete all required elements for CD-1 over the next seven months. This would allow us to achieve a formal CD-1 in the fall of 2017 – our established goal, which would keep pace with the requirements of sustaining a world-leading intensity frontier program at Fermilab.

Steve Holmes is the project manager for PIP-II.